🇪🇺 IMATINIB in European Union

IMATINIB (IMATINIB) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/002585
  • Local brand name: Imatinib Teva
  • Status: approved

IMATINIB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is IMATINIB approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for IMATINIB in European Union?

Marketing authorisation holder not available in our data.